Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults

Individuals with type 2 diabetes mellitus experience high rates of influenza virus infection and complications. We compared the magnitude and duration of serologic response to trivalent influenza vaccine in adults aged 50–80 with and without type 2 diabetes mellitus. Serologic response to influenza...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Influenza and other respiratory viruses 2022-05, Vol.16 (3), p.562-567
Hauptverfasser: Spencer, Sarah, Chung, Jessie R., Belongia, Edward A., Sundaram, Maria, Meece, Jennifer, Coleman, Laura A., Zimmerman, Richard K., Nowalk, Mary Patricia, Moehling Geffel, Krissy, Ross, Ted, Carter, Chalise E., Shay, David, Levine, Min, Liepkalns, Justine, Kim, Jin Hyang, Sambhara, Suryaprakash, Thompson, Mark G., Flannery, Brendan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 567
container_issue 3
container_start_page 562
container_title Influenza and other respiratory viruses
container_volume 16
creator Spencer, Sarah
Chung, Jessie R.
Belongia, Edward A.
Sundaram, Maria
Meece, Jennifer
Coleman, Laura A.
Zimmerman, Richard K.
Nowalk, Mary Patricia
Moehling Geffel, Krissy
Ross, Ted
Carter, Chalise E.
Shay, David
Levine, Min
Liepkalns, Justine
Kim, Jin Hyang
Sambhara, Suryaprakash
Thompson, Mark G.
Flannery, Brendan
description Individuals with type 2 diabetes mellitus experience high rates of influenza virus infection and complications. We compared the magnitude and duration of serologic response to trivalent influenza vaccine in adults aged 50–80 with and without type 2 diabetes mellitus. Serologic response to influenza vaccination was similar in both groups: greater fold‐increases in antibody titer occurred among participants with lower pre‐vaccination antibody titers. Waning of antibody titers was not influenced by diabetes status.
doi_str_mv 10.1111/irv.12933
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8983908</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2647051698</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4433-e1fda1ad7c9cf97fa8d78a9142732980b309e949e7ca2cb532e4772b14b9a5d93</originalsourceid><addsrcrecordid>eNp1kd2LVCEYhyWK9qMu-gfiQDd1Mbt-Ho83QSy1DSwEUd2KR9-zuXh0Us_E9NfnNNtQQd74qo-Pr_wQekbwBWnj0uftBaGKsQfolEiBV7QX6uGx5vgEnZVyh7HoB8EfoxPGB6HEwE_RtJ43xtYuTZ3zZoQKpSvV1KV0KXZ-npeYbiF66-tuD9XstyZArJ2P7V5bVHCtnsIC8YfptsZaH6HtdCk4yJ1xS6jlCXo0mVDg6f18jj6_e_vp6v3q5sP1-urNzcpyztgKyOQMMU5aZSclJzM4ORhFOJWMqgGPDCtQXIG0htpRMApcSjoSPiojnGLn6PXBu1nGGZxtjWYT9Cb72eSdTsbrv0-i_6pv01YPamAKD03w8l6Q07cFStWzLxZCMBHSUjTtca8okXj_1ot_0Lu05Ni-1ygusSC92gtfHSibUykZpmMzBOt9erqlp3-l19jnf3Z_JH_H1YDLA_DdB9j936TXH78clD8BVU-mlA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2647051698</pqid></control><display><type>article</type><title>Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults</title><source>MEDLINE</source><source>Wiley Online Library Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Spencer, Sarah ; Chung, Jessie R. ; Belongia, Edward A. ; Sundaram, Maria ; Meece, Jennifer ; Coleman, Laura A. ; Zimmerman, Richard K. ; Nowalk, Mary Patricia ; Moehling Geffel, Krissy ; Ross, Ted ; Carter, Chalise E. ; Shay, David ; Levine, Min ; Liepkalns, Justine ; Kim, Jin Hyang ; Sambhara, Suryaprakash ; Thompson, Mark G. ; Flannery, Brendan</creator><creatorcontrib>Spencer, Sarah ; Chung, Jessie R. ; Belongia, Edward A. ; Sundaram, Maria ; Meece, Jennifer ; Coleman, Laura A. ; Zimmerman, Richard K. ; Nowalk, Mary Patricia ; Moehling Geffel, Krissy ; Ross, Ted ; Carter, Chalise E. ; Shay, David ; Levine, Min ; Liepkalns, Justine ; Kim, Jin Hyang ; Sambhara, Suryaprakash ; Thompson, Mark G. ; Flannery, Brendan</creatorcontrib><description>Individuals with type 2 diabetes mellitus experience high rates of influenza virus infection and complications. We compared the magnitude and duration of serologic response to trivalent influenza vaccine in adults aged 50–80 with and without type 2 diabetes mellitus. Serologic response to influenza vaccination was similar in both groups: greater fold‐increases in antibody titer occurred among participants with lower pre‐vaccination antibody titers. Waning of antibody titers was not influenced by diabetes status.</description><identifier>ISSN: 1750-2640</identifier><identifier>EISSN: 1750-2659</identifier><identifier>DOI: 10.1111/irv.12933</identifier><identifier>PMID: 34859584</identifier><language>eng</language><publisher>England: John Wiley &amp; Sons, Inc</publisher><subject>Adults ; Aged ; Aged, 80 and over ; Antibodies ; Antibodies, Viral ; Antigens ; Complications ; Diabetes ; Diabetes mellitus ; Diabetes mellitus (non-insulin dependent) ; Diabetes Mellitus, Type 2 ; Enrollments ; Guillain-Barre syndrome ; Hemagglutination Inhibition Tests ; Humans ; Immunogenicity ; Influenza ; Influenza A Virus, H3N2 Subtype ; Influenza Vaccines ; Influenza, Human - prevention &amp; control ; Laboratories ; Memory ; Middle Aged ; Obesity ; Older people ; Original ; Regression analysis ; Respiratory diseases ; serologic response ; Serology ; Vaccination ; vaccine ; Vaccines ; Vaccines, Inactivated ; Viruses ; Vitamin D</subject><ispartof>Influenza and other respiratory viruses, 2022-05, Vol.16 (3), p.562-567</ispartof><rights>Published 2021. This article is a U.S. Government work and is in the public domain in the USA. published by John Wiley &amp; Sons Ltd.</rights><rights>Published 2021. This article is a U.S. Government work and is in the public domain in the USA. Influenza and Other Respiratory Viruses published by John Wiley &amp; Sons Ltd.</rights><rights>2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4433-e1fda1ad7c9cf97fa8d78a9142732980b309e949e7ca2cb532e4772b14b9a5d93</citedby><cites>FETCH-LOGICAL-c4433-e1fda1ad7c9cf97fa8d78a9142732980b309e949e7ca2cb532e4772b14b9a5d93</cites><orcidid>0000-0001-9619-4820 ; 0000-0003-1947-7469 ; 0000-0001-6786-3482 ; 0000-0002-2103-4096 ; 0000-0001-5205-966X ; 0000-0001-8056-3302 ; 0000-0002-1702-2690 ; 0000-0001-7478-0415</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983908/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983908/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,1411,11543,27903,27904,45553,45554,46030,46454,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34859584$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Spencer, Sarah</creatorcontrib><creatorcontrib>Chung, Jessie R.</creatorcontrib><creatorcontrib>Belongia, Edward A.</creatorcontrib><creatorcontrib>Sundaram, Maria</creatorcontrib><creatorcontrib>Meece, Jennifer</creatorcontrib><creatorcontrib>Coleman, Laura A.</creatorcontrib><creatorcontrib>Zimmerman, Richard K.</creatorcontrib><creatorcontrib>Nowalk, Mary Patricia</creatorcontrib><creatorcontrib>Moehling Geffel, Krissy</creatorcontrib><creatorcontrib>Ross, Ted</creatorcontrib><creatorcontrib>Carter, Chalise E.</creatorcontrib><creatorcontrib>Shay, David</creatorcontrib><creatorcontrib>Levine, Min</creatorcontrib><creatorcontrib>Liepkalns, Justine</creatorcontrib><creatorcontrib>Kim, Jin Hyang</creatorcontrib><creatorcontrib>Sambhara, Suryaprakash</creatorcontrib><creatorcontrib>Thompson, Mark G.</creatorcontrib><creatorcontrib>Flannery, Brendan</creatorcontrib><title>Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults</title><title>Influenza and other respiratory viruses</title><addtitle>Influenza Other Respir Viruses</addtitle><description>Individuals with type 2 diabetes mellitus experience high rates of influenza virus infection and complications. We compared the magnitude and duration of serologic response to trivalent influenza vaccine in adults aged 50–80 with and without type 2 diabetes mellitus. Serologic response to influenza vaccination was similar in both groups: greater fold‐increases in antibody titer occurred among participants with lower pre‐vaccination antibody titers. Waning of antibody titers was not influenced by diabetes status.</description><subject>Adults</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antibodies</subject><subject>Antibodies, Viral</subject><subject>Antigens</subject><subject>Complications</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Diabetes Mellitus, Type 2</subject><subject>Enrollments</subject><subject>Guillain-Barre syndrome</subject><subject>Hemagglutination Inhibition Tests</subject><subject>Humans</subject><subject>Immunogenicity</subject><subject>Influenza</subject><subject>Influenza A Virus, H3N2 Subtype</subject><subject>Influenza Vaccines</subject><subject>Influenza, Human - prevention &amp; control</subject><subject>Laboratories</subject><subject>Memory</subject><subject>Middle Aged</subject><subject>Obesity</subject><subject>Older people</subject><subject>Original</subject><subject>Regression analysis</subject><subject>Respiratory diseases</subject><subject>serologic response</subject><subject>Serology</subject><subject>Vaccination</subject><subject>vaccine</subject><subject>Vaccines</subject><subject>Vaccines, Inactivated</subject><subject>Viruses</subject><subject>Vitamin D</subject><issn>1750-2640</issn><issn>1750-2659</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kd2LVCEYhyWK9qMu-gfiQDd1Mbt-Ho83QSy1DSwEUd2KR9-zuXh0Us_E9NfnNNtQQd74qo-Pr_wQekbwBWnj0uftBaGKsQfolEiBV7QX6uGx5vgEnZVyh7HoB8EfoxPGB6HEwE_RtJ43xtYuTZ3zZoQKpSvV1KV0KXZ-npeYbiF66-tuD9XstyZArJ2P7V5bVHCtnsIC8YfptsZaH6HtdCk4yJ1xS6jlCXo0mVDg6f18jj6_e_vp6v3q5sP1-urNzcpyztgKyOQMMU5aZSclJzM4ORhFOJWMqgGPDCtQXIG0htpRMApcSjoSPiojnGLn6PXBu1nGGZxtjWYT9Cb72eSdTsbrv0-i_6pv01YPamAKD03w8l6Q07cFStWzLxZCMBHSUjTtca8okXj_1ot_0Lu05Ni-1ygusSC92gtfHSibUykZpmMzBOt9erqlp3-l19jnf3Z_JH_H1YDLA_DdB9j936TXH78clD8BVU-mlA</recordid><startdate>202205</startdate><enddate>202205</enddate><creator>Spencer, Sarah</creator><creator>Chung, Jessie R.</creator><creator>Belongia, Edward A.</creator><creator>Sundaram, Maria</creator><creator>Meece, Jennifer</creator><creator>Coleman, Laura A.</creator><creator>Zimmerman, Richard K.</creator><creator>Nowalk, Mary Patricia</creator><creator>Moehling Geffel, Krissy</creator><creator>Ross, Ted</creator><creator>Carter, Chalise E.</creator><creator>Shay, David</creator><creator>Levine, Min</creator><creator>Liepkalns, Justine</creator><creator>Kim, Jin Hyang</creator><creator>Sambhara, Suryaprakash</creator><creator>Thompson, Mark G.</creator><creator>Flannery, Brendan</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T2</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9619-4820</orcidid><orcidid>https://orcid.org/0000-0003-1947-7469</orcidid><orcidid>https://orcid.org/0000-0001-6786-3482</orcidid><orcidid>https://orcid.org/0000-0002-2103-4096</orcidid><orcidid>https://orcid.org/0000-0001-5205-966X</orcidid><orcidid>https://orcid.org/0000-0001-8056-3302</orcidid><orcidid>https://orcid.org/0000-0002-1702-2690</orcidid><orcidid>https://orcid.org/0000-0001-7478-0415</orcidid></search><sort><creationdate>202205</creationdate><title>Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults</title><author>Spencer, Sarah ; Chung, Jessie R. ; Belongia, Edward A. ; Sundaram, Maria ; Meece, Jennifer ; Coleman, Laura A. ; Zimmerman, Richard K. ; Nowalk, Mary Patricia ; Moehling Geffel, Krissy ; Ross, Ted ; Carter, Chalise E. ; Shay, David ; Levine, Min ; Liepkalns, Justine ; Kim, Jin Hyang ; Sambhara, Suryaprakash ; Thompson, Mark G. ; Flannery, Brendan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4433-e1fda1ad7c9cf97fa8d78a9142732980b309e949e7ca2cb532e4772b14b9a5d93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adults</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antibodies</topic><topic>Antibodies, Viral</topic><topic>Antigens</topic><topic>Complications</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Diabetes Mellitus, Type 2</topic><topic>Enrollments</topic><topic>Guillain-Barre syndrome</topic><topic>Hemagglutination Inhibition Tests</topic><topic>Humans</topic><topic>Immunogenicity</topic><topic>Influenza</topic><topic>Influenza A Virus, H3N2 Subtype</topic><topic>Influenza Vaccines</topic><topic>Influenza, Human - prevention &amp; control</topic><topic>Laboratories</topic><topic>Memory</topic><topic>Middle Aged</topic><topic>Obesity</topic><topic>Older people</topic><topic>Original</topic><topic>Regression analysis</topic><topic>Respiratory diseases</topic><topic>serologic response</topic><topic>Serology</topic><topic>Vaccination</topic><topic>vaccine</topic><topic>Vaccines</topic><topic>Vaccines, Inactivated</topic><topic>Viruses</topic><topic>Vitamin D</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Spencer, Sarah</creatorcontrib><creatorcontrib>Chung, Jessie R.</creatorcontrib><creatorcontrib>Belongia, Edward A.</creatorcontrib><creatorcontrib>Sundaram, Maria</creatorcontrib><creatorcontrib>Meece, Jennifer</creatorcontrib><creatorcontrib>Coleman, Laura A.</creatorcontrib><creatorcontrib>Zimmerman, Richard K.</creatorcontrib><creatorcontrib>Nowalk, Mary Patricia</creatorcontrib><creatorcontrib>Moehling Geffel, Krissy</creatorcontrib><creatorcontrib>Ross, Ted</creatorcontrib><creatorcontrib>Carter, Chalise E.</creatorcontrib><creatorcontrib>Shay, David</creatorcontrib><creatorcontrib>Levine, Min</creatorcontrib><creatorcontrib>Liepkalns, Justine</creatorcontrib><creatorcontrib>Kim, Jin Hyang</creatorcontrib><creatorcontrib>Sambhara, Suryaprakash</creatorcontrib><creatorcontrib>Thompson, Mark G.</creatorcontrib><creatorcontrib>Flannery, Brendan</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Influenza and other respiratory viruses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Spencer, Sarah</au><au>Chung, Jessie R.</au><au>Belongia, Edward A.</au><au>Sundaram, Maria</au><au>Meece, Jennifer</au><au>Coleman, Laura A.</au><au>Zimmerman, Richard K.</au><au>Nowalk, Mary Patricia</au><au>Moehling Geffel, Krissy</au><au>Ross, Ted</au><au>Carter, Chalise E.</au><au>Shay, David</au><au>Levine, Min</au><au>Liepkalns, Justine</au><au>Kim, Jin Hyang</au><au>Sambhara, Suryaprakash</au><au>Thompson, Mark G.</au><au>Flannery, Brendan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults</atitle><jtitle>Influenza and other respiratory viruses</jtitle><addtitle>Influenza Other Respir Viruses</addtitle><date>2022-05</date><risdate>2022</risdate><volume>16</volume><issue>3</issue><spage>562</spage><epage>567</epage><pages>562-567</pages><issn>1750-2640</issn><eissn>1750-2659</eissn><abstract>Individuals with type 2 diabetes mellitus experience high rates of influenza virus infection and complications. We compared the magnitude and duration of serologic response to trivalent influenza vaccine in adults aged 50–80 with and without type 2 diabetes mellitus. Serologic response to influenza vaccination was similar in both groups: greater fold‐increases in antibody titer occurred among participants with lower pre‐vaccination antibody titers. Waning of antibody titers was not influenced by diabetes status.</abstract><cop>England</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>34859584</pmid><doi>10.1111/irv.12933</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-9619-4820</orcidid><orcidid>https://orcid.org/0000-0003-1947-7469</orcidid><orcidid>https://orcid.org/0000-0001-6786-3482</orcidid><orcidid>https://orcid.org/0000-0002-2103-4096</orcidid><orcidid>https://orcid.org/0000-0001-5205-966X</orcidid><orcidid>https://orcid.org/0000-0001-8056-3302</orcidid><orcidid>https://orcid.org/0000-0002-1702-2690</orcidid><orcidid>https://orcid.org/0000-0001-7478-0415</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1750-2640
ispartof Influenza and other respiratory viruses, 2022-05, Vol.16 (3), p.562-567
issn 1750-2640
1750-2659
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8983908
source MEDLINE; Wiley Online Library Open Access; DOAJ Directory of Open Access Journals; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Adults
Aged
Aged, 80 and over
Antibodies
Antibodies, Viral
Antigens
Complications
Diabetes
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2
Enrollments
Guillain-Barre syndrome
Hemagglutination Inhibition Tests
Humans
Immunogenicity
Influenza
Influenza A Virus, H3N2 Subtype
Influenza Vaccines
Influenza, Human - prevention & control
Laboratories
Memory
Middle Aged
Obesity
Older people
Original
Regression analysis
Respiratory diseases
serologic response
Serology
Vaccination
vaccine
Vaccines
Vaccines, Inactivated
Viruses
Vitamin D
title Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T05%3A44%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20diabetes%20status%20on%20immunogenicity%20of%20trivalent%20inactivated%20influenza%20vaccine%20in%20older%20adults&rft.jtitle=Influenza%20and%20other%20respiratory%20viruses&rft.au=Spencer,%20Sarah&rft.date=2022-05&rft.volume=16&rft.issue=3&rft.spage=562&rft.epage=567&rft.pages=562-567&rft.issn=1750-2640&rft.eissn=1750-2659&rft_id=info:doi/10.1111/irv.12933&rft_dat=%3Cproquest_pubme%3E2647051698%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2647051698&rft_id=info:pmid/34859584&rfr_iscdi=true